Tasker Sybil 4
4 · Altimmune, Inc. · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2019-01-02+30,000→ 30,000 totalExercise: $2.60Exp: 2029-01-02→ Common Stock, par value $0.0001 (30,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date.